CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Clinical trials for CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New oral drug could stop blood condition from turning into cancer
Disease control Not yet recruitingThis study tests a low-dose oral drug (decitabine with tetrahydrouridine) in 80 people aged 60-85 with a high-risk blood condition called CCUS, which often leads to blood cancer. The drug aims to reduce harmful blood cell mutations and restore normal blood production without the …
Matched conditions: CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: Clinical Hub for Interventional Research (CHOIR) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New registry aims to track MDS and its early signs in 500 patients
Knowledge-focused Not yet recruitingThis study creates a registry of 500 adults with myelodysplastic syndromes (MDS) or related blood disorders, including early conditions like CHIP and CCUS. Researchers will collect medical data and blood samples over time to learn how these diseases develop and progress. The goal…
Matched conditions: CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Sponsor: Technische Universität Dresden • Aim: Knowledge-focused
Last updated May 17, 2026 03:29 UTC